| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 08/25/2004 | CN1523983A Method for the production of solid formulations of sodium 3-hydroxy-3-methylbutyrate |
| 08/25/2004 | CN1523982A Methods, compounds, and compositions for reducing body fat and modulating fatty acid metabolism |
| 08/25/2004 | CN1523979A Pharmaceutical compositions of adsorbates of amorphous drug |
| 08/25/2004 | CN1523041A Bulgaria inquinans polysaccharide, method for preparing the same and pharmaceutical composition using the compound as active component |
| 08/25/2004 | CN1523004A Vitamin A acid analogue and its preparing method and application |
| 08/25/2004 | CN1522753A Use of glede tea aqueous extract in preparation of diabetes preventing and curing drug |
| 08/25/2004 | CN1522752A Animal brain extract and bitter gourd extract composition and its uses |
| 08/25/2004 | CN1522731A Blood fat regulating drug or health food |
| 08/25/2004 | CN1522709A Honey containing biological selenium conversion method |
| 08/25/2004 | CN1522703A Yolk lecithin for injection and method for making same |
| 08/25/2004 | CN1163505C Anticancer polypeptide |
| 08/25/2004 | CN1163475C 4-bromo or 4-iodo phenylamino benzhydroxamic acid derivative and use as MEK inhibitor thereof |
| 08/25/2004 | CN1163267C Use of GLP-1 or analogs in treatment of stroke |
| 08/25/2004 | CN1163240C Blood fat reducing healthcare tea |
| 08/25/2004 | CN1163232C Fatty emulsing containing reducing sugar and method for sterilizing same |
| 08/24/2004 | US6780997 Such as dibenzyl(a,3-o-isopropylidiene-3-hydroxy-4-hydroxymethyl-2-methyl-5-pyridyl) hydroxymethylphosphonate which functions like pyridoxal-5'-phosphate in vivo; drug screening; antidiabetic agents |
| 08/24/2004 | US6780983 Polypeptide having water channel activity and DNA sequence |
| 08/24/2004 | US6780970 Peptides for use in the treatment and prevention of diabetes, reperfusion injuries, immunological, cardiovascular and autoimune diseases |
| 08/24/2004 | US6780884 Derivating of tryptamine and analogous compounds and pharmaceutical formulations containing them |
| 08/24/2004 | US6780874 Autoimmune disease; antiinflammatory agents; antiproliferative agent |
| 08/24/2004 | US6780869 Selective inhibitor of cox-2; antiinflammatory agent |
| 08/24/2004 | US6780868 Treatment of myocardial or peripheral ischaemia, cardiac insufficiency or pulmonary arterial hypertension |
| 08/24/2004 | US6780862 Such as amino-indazoles for treatment of central nervous system disorders |
| 08/24/2004 | US6780859 For therapy of diabetes, obesity, impaired glucose tolerance, gastrointestinal disorders, hypertriglyceridemia, hypercholesteolemia, atherosclerotic disorders, or cardiovascular disorders |
| 08/24/2004 | US6780844 Calcium phosphopeptide complexes |
| 08/24/2004 | US6780836 Treating infection or ischemic wound in a mammal by administering relaxin, a hormone which induces secretion of vascular endothelial growth factor (vegf) |
| 08/24/2004 | US6780640 Human carboxypeptidases and polynucleotides encoding the same |
| 08/24/2004 | US6780611 G protein coupled receptors; drug screening |
| 08/24/2004 | US6780609 High bone mass gene of 1.1q13.3 |
| 08/24/2004 | US6780608 Comprises chimeric polypeptides with varying calcium/caffeine sensitivity; for drug screening |
| 08/24/2004 | US6780442 Efficient method for producing compositions enriched in anthocyanins |
| 08/24/2004 | US6780431 Substituted benzylthiazolidine-2,4-dione derivatives |
| 08/24/2004 | US6780324 Preparation of sterile stabilized nanodispersions |
| 08/24/2004 | CA2347336C A1 adenosine receptor agonists |
| 08/24/2004 | CA2334415C Compositions for increasing energy in vivo |
| 08/24/2004 | CA2143610C Use of norastemizole for the treatment of allergic disorders |
| 08/24/2004 | CA2098256C Bile acid derivatives, process for their preparation and use of these compounds as pharmaceuticals |
| 08/19/2004 | WO2004070347A2 Screening for modulators of fat storage |
| 08/19/2004 | WO2004070050A2 Cyclic urea derivatives, preparation method thereof and pharmaceutical use of same as kinase inhibitors |
| 08/19/2004 | WO2004069866A1 Therapeutic molecules |
| 08/19/2004 | WO2004069855A1 Novel glycosyl transferase with consideration of activity expression mechanism and method of producing the same |
| 08/19/2004 | WO2004069838A1 Cannabinoid receptor ligands and uses thereof |
| 08/19/2004 | WO2004069818A1 Substituted heterocyclic compounds useful in the treatment of cardiovascular diseases |
| 08/19/2004 | WO2004069798A1 Melanin-concentrating hormone receptor antagonists containing piperidine derivatives as the active ingredient |
| 08/19/2004 | WO2004069781A2 7-(3,5-diisopropylphenyl) heptatrienoic acid derivatives having serum glucose reducing activity |
| 08/19/2004 | WO2004069371A1 Method of reducing impurity content in aqueous salt solution |
| 08/19/2004 | WO2004069265A1 Use of tryptophan rich peptides |
| 08/19/2004 | WO2004069259A1 Remedy for diabetes |
| 08/19/2004 | WO2004069239A1 Combination of antidiabetic drugs |
| 08/19/2004 | WO2004069236A1 Inhibitor for perioperative blood sugar elevation |
| 08/19/2004 | WO2004069229A1 Dual release anti-diabetic drugs and process of production thereof |
| 08/19/2004 | WO2004069194A2 Use of the oxidoreductase ncb50r for diagnosings and treating diabetes |
| 08/19/2004 | WO2004058717A8 Isoquinolinone derivatives and their use as therapeutic agents |
| 08/19/2004 | WO2004056763A3 Novel glucagon antagonists |
| 08/19/2004 | WO2004054356A3 Transgenic animals produced using oral administration of a genetic agent coupled to a transporting agent |
| 08/19/2004 | WO2004032716A9 Compounds for modulation of cholesterol transport |
| 08/19/2004 | WO2003092585A3 Controlled release compositions of estradiol metabolites |
| 08/19/2004 | WO2003063851A8 Composition for pharmaceutical or dietetic use for combating hair loss |
| 08/19/2004 | WO2003057134A8 Specific binding agents of human angiopoietin-2 |
| 08/19/2004 | WO2003049702A8 Vanilloid receptor ligands and their use in treatments |
| 08/19/2004 | WO2003038123A3 Methods to treat diabetes and related conditions based on polymorphisms in the tcf1 gene |
| 08/19/2004 | US20040162433 Lipoxin A4 analogs |
| 08/19/2004 | US20040162430 Branched adamantyl and noradamantyl aryl-and aralkylpiperazines with serotonin 5-HT 1A activity |
| 08/19/2004 | US20040162427 Substituted 2,6-diamino-3,5-dicyano-4-aryl-pyridines and their use as adenosine receptor-selective ligands |
| 08/19/2004 | US20040162422 adenosine derivatives having an acetylene group in the 4' position, which are adenosine A1 agonists; treating ischaemic heart disease, peripheral vascular disease or stroke or patient suffering pain, a CNS disorder, sleep apnoea or emesis |
| 08/19/2004 | US20040162415 growth and activity promotion effects on osteoblasts |
| 08/19/2004 | US20040162352 2-{6-[1-Ethyl-3-(4-trifluoromethoxyphenyl)ureido]-5,6,7,8-tetrahydronaphthalen-2-ylsulfanyl}-2-methylpropionic acid or other derivatives of tetralins and indanes; PPAR alpha modulators to treat or inhibit the progression of diabetes |
| 08/19/2004 | US20040162332 serotonin receptor ligands such as 6-(phenylsulfonyl)-2,3,4,9-tertrahydro-1H-carbazol-3-amine, used for prophylaxis of anxiety, depression, schizophrenia, Alzheimer's disease, panic, phobia, obsessive compulsive disorder, obesity, post-traumatic stress syndrome, epilepsy and nervous system disorders |
| 08/19/2004 | US20040162331 Heterocylic amines used as antidiabetic or hyperglycemic agents |
| 08/19/2004 | US20040162325 phenyloxazole- or thiazole-alkyl-1,3-dioxane or 1,3-dithiane derivatives; therapeutic drugs for lowering blood triglyceride, low-density lipoprotein cholesterol; arteriosclerosis, diabetes mellitus, hypertension, obesity |
| 08/19/2004 | US20040162313 Heterocyclic derivatives |
| 08/19/2004 | US20040162304 Estrogen receptor modulators |
| 08/19/2004 | US20040162297 For manufacture of a medicament for use in decreasing plasma free fatty acid concentration; reducing heart rate; or treating ischemic heart disease, peripheral vascular disease, stroke, pain, CNS disorder, or sleep apnoea |
| 08/19/2004 | US20040162290 For therapy of cancer, benign prostatic hypertrophy or myoma of the uterus, endometriosis, polycystic ovarian disease, uterine fibroids or precocious puberty, lupus erythematosis, irritable bowel syndrome, premenstrual syndrome, hirsutism |
| 08/19/2004 | US20040162287 Substituted cyclohexane-1,4-diamine compounds |
| 08/19/2004 | US20040162248 Preparation and diabetic use of gibberellins |
| 08/19/2004 | US20040162241 Use of GLP-1 or analogs in treatment of myocardial infarction |
| 08/19/2004 | US20040161526 Mixing cyclodextrins with food; antidiabetic agents; metabolism disease; obesity; hypotensive agents |
| 08/19/2004 | DE20306257U1 Bearbeitungsvorrichtung Processing apparatus |
| 08/19/2004 | DE10237722A1 Indol- oder Benzimidazolderivate zur Modulation der IKappaB-Kinase Indole or benzimidazole derivatives for the modulation of IkappaB kinase |
| 08/19/2004 | DE10142663B4 C2-Disubstituierte Indan-1-ol-Systeme C2-Disubstituted indan-1-ol systems |
| 08/19/2004 | CA2814767A1 Combination therapy for treating protein deficiency disorders |
| 08/19/2004 | CA2515717A1 Melanin-concentrating hormone receptor antagonists containing piperidine derivatives as the active ingredient |
| 08/19/2004 | CA2515347A1 Screening for modulators of fat storage |
| 08/19/2004 | CA2515294A1 Therapeutic agents for diabetes |
| 08/19/2004 | CA2514071A1 Therapeutic molecules |
| 08/19/2004 | CA2513631A1 Cyclic urea derivatives, preparation method thereof and pharmaceutical use of same as kinase inhibitors |
| 08/19/2004 | CA2513529A1 Substituted heterocyclic compounds useful in the treatment of cardiovascular diseases |
| 08/18/2004 | EP1447407A1 Adenosine derivatives |
| 08/18/2004 | EP1447402A1 Quinoline compound |
| 08/18/2004 | EP1447401A1 Piperidin-2-one derivative compounds and drugs containing these compounds as the active ingredient |
| 08/18/2004 | EP1447400A1 Bicyclic compound |
| 08/18/2004 | EP1447014A1 Method for reducing the glycemic index for food |
| 08/18/2004 | EP1447013A1 Method for reducing the glycemic index of food |
| 08/18/2004 | EP1447012A1 Nutritional supplement to treat macular degeneration |
| 08/18/2004 | EP1446733A2 Glycosylphosphatidylinositol containing polypeptides |
| 08/18/2004 | EP1446500A2 A method for regulating immune function in primates using the foxp3 protein |
| 08/18/2004 | EP1446487A1 Mammalian protein phosphatases |
| 08/18/2004 | EP1446419A2 Therapeutic polypeptides, nucleic acids encoding the same, and methods of use |
| 08/18/2004 | EP1446414A1 Differentially expressed genes associated with obesity and type 2 diabetes |